Why Tilray Inc. Shares Soared While Canopy Growth and Cronos Group Sank Today




 

What happened

Shares of Tilray Inc. (NASDAQ: TLRY) were up 13.9%, while Canopy Growth (NYSE: CGC) was down 11.6% and Cronos Group (NASDAQ: CRON) slipped 10.3% as of 3:05 p.m. EDT on Thursday. Tilray reported earlier in the day that it had received regulatory permits to export medical cannabis flower to Germany.

With this approval, Tilray becomes the first -- and, for now, the only -- marijuana producer to export both cannabis oil and cannabis flower products to Germany. Canopy Growth and Cronos Group currently supply cannabis oil products to the German market.

Image source: Getty Images.

So what

It's certainly a big deal for Tilray to get the green light for exporting cannabis flower products to Germany. The country is the largest marijuana market outside North America. Arcview Market Research and BDS Analytics project that total cannabis sales in Germany will increase to $1.6 billion by 2022.

There are also some bragging rights for Tilray in becoming the first company to gain approval for providing both cannabis oil and flower products to Germany. You can bet that Canopy Growth and Cronos Group would have loved to claim first-mover status in the important European market.

Tilray also now has even greater bragging rights. With today's stock-price moves, it has replaced Canopy Growth as the biggest marijuana stock in the world in terms of market cap. Canopy stood at the top of cannabis industry valuation for most of the last two years.

However, I think that Tilray's big jump in share price and the declines for Canopy Growth and Cronos Group were overdone. The cumulative swing in market caps of more than $2 billion on today's news simply isn't warranted for what is likely only a temporary advantage for Tilray.

Canopy and Cronos are both angling to supply cannabis flower products to Germany as well. And while Tilray reported that around 5% of its total Q2 revenue of $9.7 million came from international sales (primarily in Germany), Canopy announced that the German market accounted for 14% of its product revenue: 25.9 million Canadian dollars. You don't have to do currency conversions to know that Canopy has an advantage over Tilray in the important European market where it counts: in cold, hard dollars.

Now what

Everything is going gangbusters for Tilray right now. But I think it's hard to make a solid case that the company now really merits a market cap of over $11 billion.

It's also a real stretch to argue that Tilray should be worth more than Canopy Growth. After all, Canopy claims higher sales and greater production capacity. It also has a lot more cash, thanks to the recent $4 billion investment from Constellation Brands, not to mention the advantages of partnering with that leading alcoholic beverage company.

I have said for several weeks that Tilray's share price could keep climbing, but that its current rate of momentum is destined to come to an end. That's still my view. What about Canopy and Cronos? Both were due for a pullback, but I don't think that today's news is really a good reason for the stocks to drop significantly.

Over the long run, I remain optimistic about the prospects for large marijuana growers like Canopy, Cronos, and Tilray. But investors looking to jump aboard the Canadian marijuana-stock train should be very careful. This locomotive is already headed down the tracks at breakneck speed -- and the train could be derailed at some point in the not-too-distant future. I suspect that Tilray will be the first railcar off the tracks.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

COMMENTS

More Related News

Muller still has role to play for Germany - Low
Muller still has role to play for Germany - Low

The Germany coach backs the Bayern player to do well at the highest level

Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today
Why Aurora Cannabis, Canopy Growth, and Tilray Sank Today

Disappointing quarterly results and a broader market pullback hurt the big Canadian marijuana stocks -- at least temporarily.

FOOTBALL: International: Reus injured and Kroos will be rested - Germany boss Low
FOOTBALL: International: Reus injured and Kroos will be rested - Germany boss Low

Marco Reus and Toni Kroos will sit out Germany's friendly against Russia on Thursday.

Angst for German economy as car woes slam on brakes
Angst for German economy as car woes slam on brakes
  • World
  • 2018-11-14 09:57:05Z

Germany's years-long run of steady growth came to a screeching halt in the third quarter, official data showed Wednesday, with an expected bottleneck in the vital car industry matched by broader structural concerns. Federal statistics authority Destatis reported a 0.2-percent slump in gross domestic

'Mini-Merkel' calls for Syrian migrants to be returned home as CDU leadership rivals jostle for position
'Mini-Merkel' calls for Syrian migrants to be returned home as CDU leadership rivals jostle for position

One of the frontrunners to succeed Angela Merkel as leader of her political party has called for Germany to deport migrants to Syria. Annegret Kramp-Karrenbauer said asylum-seekers whose claims are rejected or who commit crimes could be returned to the war-torn country. "Certain regions of Syria could be secure enough in the foreseeable future," she told Bild newspaper.  Ms Kramp-Karrenbauer, popularly known in Germany as "mini-Merkel", is widely seen as Mrs Merkel's preferred successor. But she has been at pains to distance herself from the chancellor's controversial migrant policy in her bid for the leadership of the Christian Democrat party (CDU). Germany currently bans deportations to...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy

facebook
Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.